Besides members of the EGFR family, HER2 dimerize with other membrane-bound receptors, such as insulin-like growth factor 1 (IGF-1), leading to an increase in the phosphorylation of HER2 and consequent activation of tumor-promoting downstream signaling pathways [56]. Here, ERBB2 is linked to neoplasm.